| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/11/2014 | US20140255452 Method and apparatus for differentiating oral pouch products |
| 09/11/2014 | US20140255384 Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin |
| 09/11/2014 | US20140255372 Co-enzyme q10 formulations and methods of use |
| 09/11/2014 | US20140255352 Non-chemotherapeutic antibiotic treatment for infections in cattle |
| 09/11/2014 | US20140255317 Preparation comprising hexose-6-phosphate-modified cholesterol derivative |
| 09/11/2014 | DE102013008745A1 Anti-parodontitis-verschluss Anti-periodontitis-lock |
| 09/11/2014 | CA2845165A1 Composition for enhancing transdermal absorption of drug and patch preparation |
| 09/10/2014 | EP2774953A1 Gelatable compositions |
| 09/10/2014 | EP2774612A1 4-Methylpyrazole formulations |
| 09/10/2014 | EP2774611A1 Magnetic composition, and method for producing same |
| 09/10/2014 | EP2774609A1 Pharmaceutical compositions comprising a HMG COA reductase inhibitor |
| 09/10/2014 | EP2774608A1 Drug loaded polymeric nanoparticles and methods of making and using same |
| 09/10/2014 | EP2774606A1 Pharmaceutical composition comprising ivabradine hydrochloride polymorph IV |
| 09/10/2014 | EP2774605A1 Pharmaceutical composition comprising almotriptan malate having uniform drug distribution and potency |
| 09/10/2014 | EP2774595A2 Integrated ingestible event marker system with pharmaceutical product |
| 09/10/2014 | EP2773451A1 Multisomes: encapsulated droplet networks |
| 09/10/2014 | EP2773426A1 Combinational liposome compositions for cancer therapy |
| 09/10/2014 | EP2773414A1 Osmotically active vaginal delivery system |
| 09/10/2014 | EP2773379A2 Subcutaneous delivery of polymer conjugates of therapeutic agents |
| 09/10/2014 | EP2773354A1 Oral immediate release formulations for substituted quinazolinones |
| 09/10/2014 | EP2773348A1 Pharmaceutical composition of omeprazole |
| 09/10/2014 | EP2773333A1 Dermal delivery compositions and methods |
| 09/10/2014 | EP2773332A1 Combination of a nanoparticle comprising a charged core made of phospholipid with a protein - use for the in vitro delivery of said protein |
| 09/10/2014 | EP2773331A1 Formulations for the treatment of diabetes |
| 09/10/2014 | EP2773330A1 Processes for producing protein microparticles |
| 09/10/2014 | EP2773329A1 Pharmaceutical compositions comprising sevelamer |
| 09/10/2014 | EP2773328A2 Method of producing lipid nanoparticles for drug delivery |
| 09/10/2014 | EP2773327A1 Reprogramming of cellular adhesion |
| 09/10/2014 | EP2773326A2 Single use system for sterilely producing lipid-nucleic acid particles |
| 09/10/2014 | EP2773325A1 Liposomal corticosteroids for treatment of inflammatory disorders in humans |
| 09/10/2014 | EP2773324A2 Stable dermatological aerosol foams utilizing reactive propellants |
| 09/10/2014 | EP2773323A1 Nano-suspension process |
| 09/10/2014 | EP2773322A1 Methods for treating cancers using oral formulations of cytidine analogs |
| 09/09/2014 | US8829163 Liquid formulations for long-acting erythropoietin conjugate |
| 09/09/2014 | US8829046 3-methanesulfonylpropionitrile for treating inflammation and pain |
| 09/09/2014 | US8829020 Compounds and compositions for use in phototherapy and in treatment of ocular neovascular disease and cancers |
| 09/09/2014 | US8829019 Stable tablet containing 4,5-epoxymorphinan derivative |
| 09/09/2014 | US8829017 Methods of treating traveler's diarrhea and hepatic encephalopathy |
| 09/09/2014 | US8828980 Controlled release corticosteroid compositions and methods for the treatment of otic disorders |
| 09/09/2014 | US8828979 Salicylic acid gel |
| 09/09/2014 | US8828975 Phosphate-containing nanoparticle delivery vehicle |
| 09/09/2014 | US8828972 Formulations containing alkylphosphocholines using novel negative charge carriers |
| 09/09/2014 | US8828969 Pharmaceutical composition for relieving pain |
| 09/09/2014 | US8828968 Nanoparticle of glucidamin for treating tumor and preparation method thereof |
| 09/09/2014 | US8828959 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells |
| 09/09/2014 | US8828947 Polypeptide formulation |
| 09/09/2014 | US8828946 Composition comprising interleukin-1 receptor antagonist and corticosteroid |
| 09/09/2014 | US8828941 Composition and method for the treatment or prevention of spinal disorders |
| 09/09/2014 | US8828929 Cytotoxic T cell epitope peptide for SARS coronavirus, and use thereof |
| 09/09/2014 | US8828928 Amphiphilic peptides and peptide particles |
| 09/09/2014 | US8828474 Apparatus and methods for loading a drug eluting medical device |
| 09/09/2014 | US8828464 Whitened exine shells |
| 09/09/2014 | US8828457 Emulsions providing stable vitamin compositions and methods of forming compositions thereof |
| 09/09/2014 | US8828446 Method for reducing transplant rejection in the eye and intraocular implants for use therefor |
| 09/09/2014 | US8828445 Method for preparing nano-particles utilizing a saccharide anti-coagulant |
| 09/09/2014 | US8828444 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 09/09/2014 | US8828443 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus |
| 09/09/2014 | US8828442 Pharmaceutical solid dispersions |
| 09/09/2014 | US8828441 Active ingredient delivery system |
| 09/09/2014 | US8828440 Corticosteroids for the treatment of joint pain |
| 09/09/2014 | US8828439 Titanosilicate molecular sieve supported metallic nanodots and methods of use to adsorb noble gases |
| 09/09/2014 | US8828438 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors and HMG-CoA reductase |
| 09/09/2014 | US8828437 Thermogelling anaesthetic compositions |
| 09/09/2014 | US8828436 Methods and compositions for treating tissue using silk proteins |
| 09/09/2014 | US8828435 Buccal delivery system |
| 09/09/2014 | US8828434 Nanocomposite hydrogel and method for preparing it, for industrial and medical applications |
| 09/09/2014 | US8828433 Hydrogel bioscaffoldings and biomedical device coatings |
| 09/09/2014 | US8828432 Embedding and encapsulation of sensitive components into a matrix to obtain discrete controlled release particles |
| 09/09/2014 | US8828431 Solid oral dosage form containing an enhancer |
| 09/09/2014 | US8828430 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/09/2014 | US8828429 Release-control composition |
| 09/09/2014 | US8828428 Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
| 09/09/2014 | US8828427 Formulations of 4-amino-2-(2,6-dioxopiperidine-3-yl)isoindoline-1,3-dione |
| 09/09/2014 | US8828426 Multiparticulate L-carnitine compositions and related methods |
| 09/09/2014 | US8828425 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers |
| 09/09/2014 | US8828423 Delivery system for active components as part of an edible composition having preselected tensile strength |
| 09/09/2014 | US8828421 Method for encapsulation of orally ingested materials to alter the site of digestion, site of action, or stability |
| 09/09/2014 | US8828420 Siloxane prepolymer containing pendant cationic and polymerizable groups |
| 09/09/2014 | US8828412 Stable polyphenol containing ophthalmic emulsion for treating dry eyes |
| 09/09/2014 | US8828411 Dosage forms and methods of use thereof |
| 09/09/2014 | US8828405 Method to enhance an immune response of nucleic acid vaccination |
| 09/09/2014 | US8828383 Nanocarriers with multi-photon response elements |
| 09/09/2014 | US8828361 Tobacco alkaloid releasing chewing gum |
| 09/09/2014 | US8828360 Hair styling compositions with improved clarity and humidity resistance |
| 09/09/2014 | US8828359 Particulate materials |
| 09/09/2014 | US8828358 In situ formation of an artificial blockage to control bleeding by polymer expansion with hydrogen peroxide |
| 09/09/2014 | US8828357 Iron oxide nanoparticles as MRI contrast agents and their preparing method |
| 09/09/2014 | US8828354 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 09/09/2014 | US8827987 Percutaneous drug delivery apparatus |
| 09/09/2014 | US8827986 Remotely activated piezoelectric pump for delivery of biological agents to the intervertebral disc and spine |
| 09/09/2014 | US8827946 Intranasal granisetron and nasal applicator |
| 09/09/2014 | US8826904 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| 09/09/2014 | CA2789236C Pharmaceutical compositions and oral dosage forms of a levodopa prodrug and methods of use |
| 09/09/2014 | CA2781766C Method of stabilizing reduced coenzyme q10 |
| 09/09/2014 | CA2735952C An inserter |
| 09/09/2014 | CA2679535C Amorphous drug transdermal systems, manufacturing methods, and stabilization |
| 09/09/2014 | CA2679010C Pellets comprising an active substance matrix resistant to gastric juice |
| 09/09/2014 | CA2616480C Coated tablet with zero-order or near zero-order release kinetics |
| 09/09/2014 | CA2570877C Topical antiviral formulations |
| 09/09/2014 | CA2511718C Tablet excipient |